Conversation with The Cancer Letter Caryn Lerman on leading USC Norris: Team science is where breakthroughs emerge February 22, 2019Vol.45 No.08By Paul Goldberg
NCI invites scientists to step up competition for $173 million set-aside for commercialization February 22, 2019Vol.45 No.08By Paul Goldberg
Drugs & Targets European Commission approves Sprycel + chemo for pediatric February 15, 2019Vol.45 No.07
Drugs & Targets FDA grants Priority Review for Keytruda in head and neck squamous cell carcinoma February 15, 2019Vol.45 No.07
Drugs & Targets FDA accepts sBLA and grants Priority Review for Bavencio + Inlyta in RCC February 15, 2019Vol.45 No.07
Clinical Roundup Keytruda + Inlyta improves OS, PFS and ORR vs. Sunitinib in RCC February 15, 2019Vol.45 No.07
Clinical Roundup Immunotherapy appears better than chemotherapy for skin cancer February 15, 2019Vol.45 No.07
Clinical Roundup Group of lymph nodes to determine prognosis for mesothelioma February 15, 2019Vol.45 No.07
